Association of CYP1A1 rs1048943 Polymorphism with Prostate Cancer in Iraqi Men Patients

Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3839-3842. doi: 10.31557/APJCP.2019.20.12.3839.

Abstract

Objective: The purpose of this study was to evaluate the relationship between CYP1A1 gene rs1048943 polymorphism and the risk of Iraqi men with prostate cancer.

Methods: In this research, we conducted a population-based approach that intersects high-throughput genotype information from different population of Iraq to estimate the frequency of genotypes associated with prostate cancer responsivenessOur study included a total of 100 patients and 150 healthy controls. rs1048943 genotyping has been investigated in Iraqi men in connection with prostate cancer.

Results: We observed that individuals with the rs1048943 GA genotype had an increased risk of prostate cancer relative to those with the AA genotype ( OR 95% CI of 0.449 :95%CI 0.23-0.90; P = 0.002). We found in the dominant model that the rs1048943 GA and GG genotype displayed an increased risk of prostate cancer relative to the AA genotype ( OR 95% CI of 0.680 :95%CI 0.4-1.17; P = 0.018).

Conclusion: Polymorphism RS 1048943 in the CYP1A1 gene is associated with the risk of developing prostate cancer and is possibly one of the most significant factors in its development.<br />.

Keywords: CYP1A1; Genotype; Prostate Cancer; rs1048943.

MeSH terms

  • Case-Control Studies
  • Cytochrome P-450 CYP1A1 / genetics*
  • Follow-Up Studies
  • Genetic Predisposition to Disease*
  • Humans
  • Iraq / epidemiology
  • Male
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Prostatic Neoplasms / epidemiology*
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / pathology
  • Risk Factors

Substances

  • CYP1A1 protein, human
  • Cytochrome P-450 CYP1A1